Drug Trial Radar · NCT01610245
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Last checked: Nov 20, 2026Latest source record: Mar 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,941
Actual
Start
Mar 2013
Primary completion
Mar 2015
Study completion Apr 16, 2015
Sponsor
- Lead sponsor
- Romark Laboratories L.C.Industry
- Sponsor type
- Industry
- First posted
- Jun 1, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a global multicenter randomized factorial double-blind, placebo-controlled trial designed to evaluate (i) efficacy and safety of nitazoxanide 600 mg administered orally twice daily for five days compared to a placebo in the treatment of acute uncomplicated influenza and (ii) efficacy and safety of combination therapy with nitazoxanide 600 mg plus Oseltamivir 75 mg co-administered orally twice daily for five days compared to nitazoxanide monotherapy (600 mg b.i.d. for 5 days) and Oseltamivir monotherapy (75 mg b.i.d. for 5 days) in the treatment of acute uncomplicated influenza.
Conditions
- Influenza
Interventions
NitazoxanideDrug
OseltamivirDrug
Placebo Oral TabletDrug
Placebo Oral CapsuleDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to resolution of all clinical symptoms of influenza as reported by the subjectsTime frame: Up to 28 days
Locations
167 sites in 5 countries. Site status is shown where the registry gives one.
Influence Study Site
Birmingham, Alabama
Influence Study Site
Dothan, Alabama
Influence Study Site
Hoover, Alabama
Influence Study Site
Mobile, Alabama
Influence Study Site
Mesa, Arizona
Influence Study Site
Mesa, Arizona
Influence Study Site
Tucson, Arizona
Influence Study Site
Hot Springs, Arkansas
Influence Study Site
Jonesboro, Arkansas
Influence Study Site
Anaheim, California
Influence Study Site
Fresno, California
Influence Study Site
Garden Grove, California
Influence Study Site
Harbor City, California
Influence Study Site
Huntington Beach, California
Influence Study Site
Lomita, California
Influence Study Site
Long Beach, California
Influence Study Site
Modesto, California
Influence Study Site
Norco, California
Influence Study Site
San Ramon, California
Influence Study Site
Stockton, California
Influence Study Site
Centennial, Colorado
Influence Study Site
Colorado Springs, Colorado
Influence Study Site
Colorado Springs, Colorado
Influence Study Site
Littleton, Colorado
Influence Study Site
Longmont, Colorado
Influence Study Site
Thornton, Colorado
Influence Study Site
Boynton Beach, Florida
Influence Study Site
Coral Gables, Florida
Influence Study Site
Edgewater, Florida
Influence Study Site
Kissimmee, Florida
Influence Study Site
Lauderdale Lakes, Florida
Influence Study Site
Miami, Florida
Influence Study Site
Orlando, Florida
Influence Study Site
Pembroke Pines, Florida
Influence Study Site
Saint Cloud, Florida
Influence Study Site
West Palm Beach, Florida
Influence Study Site
Atlanta, Georgia
Influence Study Site
Canton, Georgia
Influence Study Site
Columbus, Georgia
Influence Study Site
Blackfoot, Idaho
Showing 40 of 167 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.